The landscape of women’s endocrine health is undergoing a massive transformation, with the synthetic progestin market share expanding as clinical applications diversify. Synthetic progestins are no longer limited to basic contraception; they are now at the center of complex therapies for endometriosis, oncology-related hormone suppression, and advanced fertility protocols. This evolution...